Browsing Tag
Evercore ISI
12 posts
Is Parabilis Medicines’ $670m Nasdaq IPO a biotech comeback signal or a high-risk oncology wager?
Find out how Parabilis Medicines’ upsized Nasdaq IPO reshapes biotech financing, Regeneron validation and investor appetite for Helicon platform drugs now.
Quantinuum IPO closes at $1.68bn, but QNT trading shows investors want proof beyond quantum hype
Quantinuum raised $1.68bn, but QNT’s early trading asks the real question: can quantum computing turn promise into revenue?
lululemon athletica ends four-month CEO search with Heidi O’Neill appointment as LULU falls 5%
lululemon names Nike veteran Heidi O'Neill as CEO from September 8. LULU stock falls 5%. What her appointment means for the brand reset. Read more.
Nike (NYSE: NKE) at 11-year lows: Is the Swoosh a value trap or a 2027 recovery bet?
Nike (NKE) is trading at USD 42.62, near 11-year lows. Tariffs, China and a delayed turnaround have rattled investors. Here is what the next catalyst means for NKE shareholders.
Suja Life files for Nasdaq IPO as better-for-you beverage growth meets public market scrutiny
Suja Life has filed for a Nasdaq IPO. Read why its growth, debt load, brand mix, and category timing matter more than the filing itself.
IBM and ElevenLabs bring enterprise-grade voice AI to watsonx Orchestrate, targeting regulated sectors at scale
IBM integrates ElevenLabs voice AI into watsonx Orchestrate with HIPAA and PCI controls, targeting healthcare, banking, and government. Read the full analysis.
Why KB Home is holding its $0.25 dividend steady despite housing market turbulence
KB Home keeps its $0.25 quarterly dividend. Find out what this means for investors, housing market sentiment, and dividend stability in 2025.
Enanta (NASDAQ: ENTA) prices $65m offering at $10 per share — Is this a lifeline or a warning sign?
Enanta Pharmaceuticals (NASDAQ: ENTA) raises $65M in stock offering at $10 per share. Explore dilution risks, investor sentiment, and future outlook.
Fermi America prices IPO at $21 per share ahead of Nasdaq and London listings
Fermi America prices IPO at $21, dual-listing on Nasdaq and London. Find out why investors see FRMI as a bold bet on AI-driven energy grids.
Why Evercore ISI hired Alexander Virgo now—and what it means for global industrial research
Evercore ISI hires Alexander Virgo as senior managing director in London to boost global industrial research. Find out what this means for sector coverage.